Proteins from Avastin® (bevacizumab) show tyrosine nitrations for which the consequences are completely unclear.

Avastin® (bevacizumab) is a protein drug widely used for cancer treatment although its further use is questionable due to serious side effects reported. As no systematic proteomic study on posttranslational modifications (PTMs) was reported so far, it was the aim of the current study to use a gel-ba...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jia Wan, Edina Csaszar, Wei-Qiang Chen, Kongzhao Li, Gert Lubec
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2012
Materias:
R
Q
Acceso en línea:https://doaj.org/article/9856473a8af342a69c4c0b6cc2f6c8f6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9856473a8af342a69c4c0b6cc2f6c8f6
record_format dspace
spelling oai:doaj.org-article:9856473a8af342a69c4c0b6cc2f6c8f62021-11-18T07:22:06ZProteins from Avastin® (bevacizumab) show tyrosine nitrations for which the consequences are completely unclear.1932-620310.1371/journal.pone.0034511https://doaj.org/article/9856473a8af342a69c4c0b6cc2f6c8f62012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22523550/?tool=EBIhttps://doaj.org/toc/1932-6203Avastin® (bevacizumab) is a protein drug widely used for cancer treatment although its further use is questionable due to serious side effects reported. As no systematic proteomic study on posttranslational modifications (PTMs) was reported so far, it was the aim of the current study to use a gel-based proteomics method for determination of Avastin®-protein(s). Avastin® was run on two-dimensional gel electrophoresis (2-DE), spots were picked, followed by multi-enzyme in-gel digestion. Subsequently, the resulting peptides and posttranslational modifications were identified by mass spectrometry (nano-LC-ESI-MS/MS; HCT and LTQ Orbitrap MS). Heavy and light chains were observed and the 9 spots that were picked from 2DE-gels were identified as bevacizumab with high sequence coverage. MS/MS results showed multiple tyrosine nitrations on the Avastin® light and heavy chains that were either represented as nitrotyrosine or as aminotyrosine, which was shown to be generated from nitrotyrosine under reducing conditions. Protein nitration is known to significantly change protein functions and interactions and it may well be that some of the adverse effects of the protein drug Avastin® may be due to this PTM, which may have been generated during production--thus, nitration of Avastin® is a challenge for the pharmaceutical industry.Jia WanEdina CsaszarWei-Qiang ChenKongzhao LiGert LubecPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 4, p e34511 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Jia Wan
Edina Csaszar
Wei-Qiang Chen
Kongzhao Li
Gert Lubec
Proteins from Avastin® (bevacizumab) show tyrosine nitrations for which the consequences are completely unclear.
description Avastin® (bevacizumab) is a protein drug widely used for cancer treatment although its further use is questionable due to serious side effects reported. As no systematic proteomic study on posttranslational modifications (PTMs) was reported so far, it was the aim of the current study to use a gel-based proteomics method for determination of Avastin®-protein(s). Avastin® was run on two-dimensional gel electrophoresis (2-DE), spots were picked, followed by multi-enzyme in-gel digestion. Subsequently, the resulting peptides and posttranslational modifications were identified by mass spectrometry (nano-LC-ESI-MS/MS; HCT and LTQ Orbitrap MS). Heavy and light chains were observed and the 9 spots that were picked from 2DE-gels were identified as bevacizumab with high sequence coverage. MS/MS results showed multiple tyrosine nitrations on the Avastin® light and heavy chains that were either represented as nitrotyrosine or as aminotyrosine, which was shown to be generated from nitrotyrosine under reducing conditions. Protein nitration is known to significantly change protein functions and interactions and it may well be that some of the adverse effects of the protein drug Avastin® may be due to this PTM, which may have been generated during production--thus, nitration of Avastin® is a challenge for the pharmaceutical industry.
format article
author Jia Wan
Edina Csaszar
Wei-Qiang Chen
Kongzhao Li
Gert Lubec
author_facet Jia Wan
Edina Csaszar
Wei-Qiang Chen
Kongzhao Li
Gert Lubec
author_sort Jia Wan
title Proteins from Avastin® (bevacizumab) show tyrosine nitrations for which the consequences are completely unclear.
title_short Proteins from Avastin® (bevacizumab) show tyrosine nitrations for which the consequences are completely unclear.
title_full Proteins from Avastin® (bevacizumab) show tyrosine nitrations for which the consequences are completely unclear.
title_fullStr Proteins from Avastin® (bevacizumab) show tyrosine nitrations for which the consequences are completely unclear.
title_full_unstemmed Proteins from Avastin® (bevacizumab) show tyrosine nitrations for which the consequences are completely unclear.
title_sort proteins from avastin® (bevacizumab) show tyrosine nitrations for which the consequences are completely unclear.
publisher Public Library of Science (PLoS)
publishDate 2012
url https://doaj.org/article/9856473a8af342a69c4c0b6cc2f6c8f6
work_keys_str_mv AT jiawan proteinsfromavastinbevacizumabshowtyrosinenitrationsforwhichtheconsequencesarecompletelyunclear
AT edinacsaszar proteinsfromavastinbevacizumabshowtyrosinenitrationsforwhichtheconsequencesarecompletelyunclear
AT weiqiangchen proteinsfromavastinbevacizumabshowtyrosinenitrationsforwhichtheconsequencesarecompletelyunclear
AT kongzhaoli proteinsfromavastinbevacizumabshowtyrosinenitrationsforwhichtheconsequencesarecompletelyunclear
AT gertlubec proteinsfromavastinbevacizumabshowtyrosinenitrationsforwhichtheconsequencesarecompletelyunclear
_version_ 1718423549555769344